Alliancebernstein L.P. Takeda Pharmaceutical CO LTD Transaction History

Alliancebernstein L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.12 - $15.03 $3.3 Million - $3.78 Million	-251,187 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$13.54 - $15.35 $661,794 - $750,261	48,877 Added 24.16%	251,187 $3.6 Million
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $2.66 Million - $3.32 Million	202,310 New	202,310 $2.76 Million
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $8.85 Million - $9.86 Million	-548,154 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $6.66 Million - $8.23 Million	-401,865 Reduced 42.3%	548,154 $9.7 Million
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $15.9 Million - $20.4 Million	950,019 New	950,019 $19.4 Million

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.